Cardiovascular disease risk in patients with psoriasis receiving biologics targeting TNF-α, IL-12/23, IL-17, and IL-23: A population-based retrospective cohort study
Patients with psoriasis prescribed biologics exhibited a lower risk of CVDs versus those on oral therapy. Anti-TNF-α, anti-IL-17, and anti-IL-23 were associated with decreased cardiovascular hazards, while anti-IL-12/23 was not.
Authors
- Teng‐Li Lin (ORCID: https://orcid.org/0000-0002-0639-3533)
- Chao-Kuei Juan
- Yi‐Hsuan Fan
- Chun-Ying Wu (ORCID: https://orcid.org/0000-0003-4207-2312)
- Kuo-Sheng Fan
Institutions
- National Yang Ming Chiao Tung University (TW)
- National Chung Hsing University (TW)
- China Medical University (TW)
- Taipei Veterans General Hospital (TW)
- Taichung Veterans General Hospital (TW)
- Chung Shan Medical University Hospital (TW)
Publication Details
- Journal
- PLoS Medicine
- Published
- 2025-04-17
- DOI
- https://doi.org/10.1371/journal.pmed.1004591
- Citations
- 16
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 12.76
Funders
- Taichung Veterans General Hospital